| Filed On | Filing |
|---|---|
| 28 Oct 2026 | 10-K |
| 26 Jun 2026 |
8-K: Regulation FD Disclosure
The accompanying Unaudited Condensed Interim Consolidated Financial Statements of BriaPro Therapeutics Corp. for the three and nine month periods ended April 30, 2026 and 2025 have been prepared by management in accordance with Internati... |
| 09 Jun 2026 | 10-Q |
| 03 Jun 2026 |
8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
This Placement Agency Agreement (the “Agreement”) sets forth the terms upon which ThinkEquity LLC (“ThinkEquity” or the “Placement Agent”) shall be engaged by BriaCell Therapeutics Corp., a corporation formed under the laws of the Provin... |
| 02 Jun 2026 | 424B5 |
| 31 Mar 2026 |
8-K: Regulation FD Disclosure
The following Management’s Discussion and Analysis (“MD&A”) for BRIAPRO THERAPEUTICS CORP. (“BriaPro” or the “Company”) is prepared as of March 31, 2026 and relates to the unaudited condensed interim financial condition and results of op... |
| 10 Mar 2026 | 10-Q |
| 09 Mar 2026 |
8-K: Submission of Matters to a Vote of Security Holders
On March 5, 2026, BriaCell Therapeutics Corp. (the “Company”) held its Annual General and Special Meeting of Shareholders (the “Meeting”). As of January 26, 2026, the date of record for determining the shareholders entitled to vote on th... |
| 26 Feb 2026 | 25-NSE |
| 20 Feb 2026 |
8-K: Other Events
PHILADELPHIA and VANCOUVER, British Columbia, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, BCTXL) (TSX: BCT) (“BriaCell”), a clinical-stage biotechnology company that develops novel immunothe... |
| 12 Feb 2026 | DEF 14A |
| 23 Jan 2026 | SCHEDULE 13G |
| 15 Jan 2026 |
8-K: Entry into a Material Definitive Agreement; Other Events
This Placement Agency Agreement (the “Agreement”) sets forth the terms upon which ThinkEquity LLC (“ThinkEquity” or the “Placement Agent”) shall be engaged by BriaCell Therapeutics Corp., a corporation formed under the laws of the Provin... |
| 14 Jan 2026 | 424B4 |
| 13 Jan 2026 | EFFECT |
| 13 Jan 2026 | S-1MEF |
| 13 Jan 2026 | CERT |
| 13 Jan 2026 | 8-A12B |
| 08 Jan 2026 | CORRESP |
| 08 Jan 2026 | CORRESP |
Loading...